News
Amryt Pharma PLC - Final Results
RNS Number: 0941 L Amryt Pharma PLC 17 April 2018 17 April 2018. The dramatic increase in revenues to €12.8 m reflected a full year's contribution from sales of Lojuxta, which is used to treat the rare, life-threatening cholesterol disorder, HoFH. We remain in a very good position to expand Lojuxta sales further, having secured a number of distribution...
RNS Number: 0941 L Amryt Pharma PLC 17 April 2018 17 April 2018. The dramatic increase in revenues to €12.8 m reflected a full year's contribution from sales of Lojuxta, which is used to treat the rare, life-threatening cholesterol disorder, HoFH. We remain in a very good position to expand Lojuxta sales further, having secured a number of distribution...